Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation and High Intensity Focused Ultrasound (HIFU)), Mode of Treatment (Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation), Application (Liver Cancer, Lung Cancer, Kidney Cancer, Bone Metastasis, Breast Cancer and Prostate Cancer), End Users (Hospitals and Cancer Specialty Centers) – Analysis & Forecast 2019-2030

Tumor Ablation Market Overviews and Introduction

Global Tumor Ablation is estimated to be over US$ 545.3 Mn in 2018. It is anticipated to grow at 11.1% CAGR from 2019 to 2030

Tumor ablation is referred to as a minimally invasive technique that is commonly used in the treatment of tumors of the liver, kidney, bone, and lung among others. It can be used as a first-line treatment or in cases of failed chemotherapy or radiotherapy or for any non-surgical candidates. Ablation systems in general comprise of a generator and a needlelike device that delivers the energy directly to the targeted tissue to cause acute cellular necrosis.

The tumor ablation market is witnessing growth due to factors such as growing geriatric population and increasing cancer population. Moreover, technological advancement in ablation devices will further fuel the growth of tumor ablation over the forecast period. However, high cost of tumor ablation treatment is likely to restrain the market to a certain extent.

Tumor Ablation Market by Technology

On the basis of technology, the tumor ablation market is segmented into radiofrequency ablation, microwave ablation, cryoablation, high intensity focused ultrasound (HIFU) and other products. The radiofrequency ablation segment is estimated to account for the largest share in the global tumor ablation market. The large share of this technology segment can be attributed to the wide scale application of this technology for several treatments, namely lung, small liver, bone & kidney tumors among others.

Tumor Ablation Market by Mode of Treatment

On the basis of mode of treatment, the market can be segmented into surgical ablation, laparoscopic ablation and percutaneous ablation. In terms of market share, the segment of percutaneous ablation is estimated to account for the largest market share, owing to the fact that percutaneous approach is the first choice of treatment if technically feasible followed by surgical ablation and laparoscopic ablation.

Tumor Ablation Market by Mode of Application

On the basis of mode of application the tumor ablation market can be segmented into liver cancer, lung cancer, kidney cancer, bone metastasis, breast cancer, prostate cancer and other applications. The lung cancer segment is expected to account for the largest share of the tumor ablation market. The segment of lung cancer which includes percutaneous ablation treatment is an effective technique in the treatment of Non-small Cell Lung Cancer (NSCLC). Moreover, Lung cancer is considered to be the second most common form of cancer among both men and women.

Tumor Ablation Market by End User

Based on the end users, the market is segmented into hospitals and cancer specialty centers.  The hospital segment is estimated to account for the largest share of the global tumor ablation market. The large share of this segment can be attributed to rapid adoption of tumor ablation treatment equipment. Moreover, favorable regulations and rising support from government institutions has been pivotal in contributing to the growing inclination of patients to receive healthcare services from hospitals and this is expected to further fuel the growth of hospital segment.

Tumor Ablation Market by Region

The global tumor ablation market can be segmented into North America, Europe, Asia Pacific, and Rest of World (ROW). North America dominated the market of tumor ablation, followed by Europe and Asia Pacific. North America will continue to dominate the global tumor ablation market in the forecast period owing to factors such advanced healthcare infrastructure, the rising number of cancer patients specially lung and breast cancer cases, availability of wide range of treatment options, and technological advancements among others.  However, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered in China, Japan and India. Factors such as increasing prevalence of various types of cancers, rising adoption of minimally invasive surgical procedures by patients for treatment, increasing research & development in healthcare sector and advancement in technologies of tumor ablation devices are the factors that play an important role in boosting the tumor ablation market in this region.

Tumor Ablation Market Prominent Players

The prominent players in the global tumor ablation market are Medtronic, Integra LifeSciences Corporation, AngioDynamics, Boston Scientific Corporation, NeuWave Medical, Inc. (Johnson & Johnson Services, Inc.), Galil Medical Inc. (BTG International Ltd), Misonix, HealthTronics, Inc., Sonacare Medical, MERMAID MEDICAL A/S among others.